Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		236 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Cash flows from operating activities:
Net loss	$ (614,209)	$ (1,610,147)	$ (197,660,277)
Adjustments to reconcile net loss to net cash used for operating activities:
Purchased in-process research and development			12,146,544
Write-off of acquired technology			3,500,000
Loss on disposition of assets			3,391
Interest expense settled through issuance of notes payable			350,500
Expenses satisfied with the issuance of stock			28,680
Forgiveness of debt			(476,837)
Gain on early extinguishment of debt			(6,277,100)
Non-cash gain on restricted stock valuation			(58,814)
Non-cash interest expense			3,966,394
Non-cash charges related to options, warrants and common stock		834	11,115,437
Amortization of financing costs		6,842	25,188
Amortization and depreciation	893	27,274	2,891,559
Changes in operating assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets	(39,043)	(24,112)	461,320
Increase (decrease) in accounts payable and accrued expenses	86,813	(769,025)	2,001,215
Increase in accrued interest payable	208,255	911,222	8,023,052
Decrease in accrued lease		(96,425)
Net cash used for operating activities	(357,291)	(1,553,537)	(159,959,748)
Cash flows from investing activities:
Cash acquired through Merger			1,758,037
Purchases of property and equipment			(1,654,487)
Proceeds from the sale of property and equipment			3,430
Decrease (increase) in security deposits and other assets		88,600
Decrease in indemnity fund		85
Purchases of marketable securities			(132,004,923)
Sales and maturities of marketable securities			132,004,923
Net cash provided by investing activities		88,685	106,980
Cash flows from financing activities:
Proceeds from issuance of common stock			66,731,339
Buyback of common stock			(26,356)
Proceeds from issuance of preferred stock			39,922,170
Preferred stock conversion inducement			(600,564)
Proceeds from issuance of promissory notes	285,000	1,440,000	58,770,000
Proceeds from issuance of convertible debentures			9,000,000
Principal payments of notes payable/repurchase of debt			(7,750,667)
Dividend payments on Series E Cumulative Convertible Preferred Stock			(516,747)
Payments of financing costs			(5,612,855)
Net cash provided by financing activities	285,000	1,440,000	159,916,320
Net (decrease) increase in cash and cash equivalents	(72,291)	(24,852)	63,552
Cash and cash equivalents, beginning of period	135,843	98,514
Cash and cash equivalents, end of period	63,552	73,662	63,552
Supplemental cash flow disclosures:
Cash paid for interest			628,406
Supplemental disclosure of non-cash financing activity:
Conversion of notes payable to common stock			7,172,412
Capital contribution related to forgiveness of accrued interest			6,328,306
Accrued interest reclassified in connection with conversion of Series F convertible redeemable preferred stock to common stock			$ 640,874